Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Laversin, Stephanie Anne‐Sophie
8  Ergebnisse:
Personensuche X
?
1

Serum biomarkers which correlate with failure to respond to..:

Vafadar‐Isfahani, Baharak ; Laversin, Stephanie Anne‐Sophie ; Ahmad, Murrium...
PROTEOMICS – Clinical Applications.  4 (2010)  8-9 - p. 682-696 , 2010
Link: https://doi.org/10.1002/..
 
?
2

A study of macrophage activatory to inhibitory FcɣR ratio i..:

Krishnan, Jamie Varun ; Schapira, Aron ; Copson, Ellen...
European Journal of Surgical Oncology (EJSO).  39 (2013)  11 - p. S71-S72 , 2013
Link: https://doi.org/10.1016/..
 
?
3

Identification of novel breast cancer‐associated transcript..:

Laversin, Stéphanie A.‐S. ; Phatak, Vinaya M. ; Powe, Des G....
Genes, Chromosomes and Cancer.  52 (2012)  3 - p. 316-329 , 2012
Link: https://doi.org/10.1002/..
 
?
4

Prognostic significance of crown-like structures to trastuz..:

Birts, Charles N. ; Savva, Constantinos ; Laversin, Stéphanie A....
Scientific Reports.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
5

The effects of restricted glycolysis on stem-cell like char..:

Banerjee, Arindam ; Arvinrad, Pardis ; Darley, Matthew...
Oncotarget.  9 (2018)  33 - p. 23274-23288 , 2018
Link: https://doi.org/10.18632..
 
?
6

A novel spontaneous model of epithelial-mesenchymal transit..:

Harner-Foreman, Naomi ; Vadakekolathu, Jayakumar ; Laversin, Stéphanie A....
Scientific Reports.  7 (2017)  1 - p. , 2017
Link: https://doi.org/10.1038/..
 
?
7

A combination of trastuzumab and BAG-1 inhibition synergist..:

Papadakis, Emmanouil ; Robson, Natalia ; Yeomans, Alison...
Oncotarget.  7 (2016)  14 - p. 18851-18864 , 2016
Link: https://doi.org/10.18632..
 
?
8

Immunotherapy of prostate cancer: should we be targeting st..:

Dunning, Naomi L. ; Laversin, Stéphanie A. ; Miles, Amanda K..
Cancer Immunology, Immunotherapy.  60 (2011)  8 - p. 1181-1193 , 2011
Link: https://doi.org/10.1007/..
 
1-8